Monograph

From Office of Health Economics
Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).

Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

000443: Our Certain Fate: Rationing in Health Care

Alan Maynard

000442: National Health Service Reorganisation: Learning from History?

Charles Webster

000441: Managed Care - An Option for the German Health Care System?

Robert Seitz;Hans-Helmut Konig;Eleni Jelastopulu

000440: Managed Care - A Model for the UK?

Peter West

000437: Effective Commissioning: Lessons from purchasing in American managed care

Donald W. Light

000435: Controlling NHS Expenditure: The Impact of Labour’s NHS White Papers

Office of Health Economics

000434: Competition through Innovation, Innovation through Competition

Hannah Kettler

000433: Competition and contestability between acute hospitals

Office of Health Economics

000432: Biotechnology and the Economics of Discovery in the Pharmaceutical Industry

Helen Simpson

000431: Accountable Health Care: Is it compatible with social solidarity?

Uwe Reinhardt

000430: Trade and Price Differentials for Pharmaceuticals: Policy Options

Patricia Danzon

000429: Theory and Evidence on Cost Sharing in Health Care: An Economic Perspective

Martin Chalkley

000425: NHS Waiting Lists: Towards the Elusive Solution

Rhiannon Tudor Edwards

000423: Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK learn from Australia and Canada?

Adrian Towse

000421: Drivers of the Growth in Medicines Expenditure

Nick Marchant

000420: Using Consumer Preferences in Health Care Decision Making: The Application of Conjoint Analysis

Mandy Ryan

000419: Uses of Models in Economic Evaluations of Medicines and Other Health Technologies

Brian Rittenhouse

000418: The Future of Primary Care

Jane Griffin

000417: The Doctor's (Ethical and Economic) Dilemma

David L. Sackett

000415: Value of the Pharmaceutical Industry to the UK Economy

Adrian Towse

000414: Industrial Policy and the Pharmaceutical Industry

Adrian Towse

000413: Hypothecated Health Taxes: An evaluation of recent proposals

Andrew Jones;Alan Duncan

000412: Health Information and the Consumer

Jane Griffin

000411: Health Care as a Handicraft Industry

William Baumol

000409: Financing Health Care in the UK: A Discussion of NERA’s Prototype Model to Replace the NHS

Adrian Towse

000405: Managing the NHS: past, present and agenda for the future

William Laing

000402: A Doctor Looks at Health Economics

Sir Douglas Black

000400: Science in Medicine: How Far Has It Advanced?

George Teeling Smith;Cynthia Roberts

000397: Innovative Competition in Medicine

George Teeling Smith

000394: AIDS: Worldwide Policies and Problems

Mildred Blaxter

000377: Measuring the Benefits of Medicines: The Future Agenda

George Teeling Smith

000373: People as Patients and Patients as People

Office of Health Economics

000370: Holes in Therapy

Christopher C. Booth

000366: Measuring Health: a Practical Approach

George Teeling Smith

000365: Innovative Chemical Extensions: The Economic Basis of Pharmaceutical Progress

Nick Wells

000361: Economic Evaluation and Develop Medicines in the Development of Medicines

Michael F. Drummond;George Teeling Smith;Nick Wells

000358: Health Economics: Prospects for the Future

George Teeling Smith

000357: Cost and Benefits of Pharmaceutical Research

George Teeling Smith

000351: Health, Education and General Practice

George Teeling Smith

000346: Techniques of Health Status Measurement Using a Health Index

Gillian Holland

000344: Patterns of European Diagnoses and Prescribing

Bernie O'Brien

000342: New NHS Act for 1996?

George Teeling Smith

000341: Second Pharmacological Revolution

Office of Health Economics

000340: Future for Pharmaceuticals: the Potential; the Pattern and the Problems

George Teeling Smith

000339: Consumer Movement, Health, and the Pharmaceutical Industry

David Taylor

000338: Pharmaceuticals in Developing Countries

Arnold Worlock

000336: Measuring the Social Benefits of Medicine

George Teeling Smith

000334: Issues in Development: a Guide

Klaus M. Leisinger

000333: Needs of the Pharmaceutical Manufacturers from Their Medical Departments in the 1980s

George Teeling Smith

000326: Adverse Reactions and the Community

George Teeling Smith